Genus PLC Director/PDMR Shareholding (2066Y)
March 01 2017 - 4:09AM
UK Regulatory
TIDMGNS
RNS Number : 2066Y
Genus PLC
01 March 2017
1 March 2017
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that today, in accordance with
the terms of joining contained in his employment contract, Dr. Nate
Zwald, Chief Operating Officer, Genus ABS Dairy, was granted
contingent rights over 7,225 ordinary shares in Genus under an
individual award agreement as follows: 3,613 and 3,612 ordinary
shares with a normal vesting date of 5 January 2018 and 5 January
2019 respectively.
Subject to the terms of the individual award agreement and
continued service, the award will vest on the normal vesting dates
as specified above.
No consideration was paid for the grant of this award and no
consideration is due in connection with the exercise of this
award.
The below notification, made in accordance with the requirements
of the EU Market Abuse Regulation, gives further detail of the
individual award agreement made on 1 March 2017.
For further information please contact:
Genus:
Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256
347100
1. Details of the person discharging managerial
responsibilities / person closely associated
=== =====================================================================
a. Name Dr. Nate Zwald
=== ============================== =====================================
2. Reason for the notification
=== =====================================================================
a. Position/status Chief Operating Officer, Genus
ABS Dairy
=== ============================== =====================================
b. Initial notification Initial notification
/Amendment
=== ============================== =====================================
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =====================================================================
a. Name Genus plc
=== ============================== =====================================
b. LEI 54930022EOITNKSIGH56
=== ============================== =====================================
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
=== =====================================================================
a. Description Ordinary shares of 10p each
of the
Financial
instrument, GB0002074580
type of instrument
Identification
code
=== ============================== =====================================
b. Nature of Grant of contingent rights over
the transaction 7,225 ordinary shares in Genus
under an individual award agreement
=== ============================== =====================================
c. Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
1. 0p 7,225
--------- ----------
=== ============================== =====================================
d. Aggregated
information
* Aggregated volume n/a
* Price
=== ============================== =====================================
e. Date of the 2017-03-01
transaction
=== ============================== =====================================
f. Place of the London Stock Exchange, Main Market
transaction (XLON)
=== ============================== =====================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUARRRBWAORAR
(END) Dow Jones Newswires
March 01, 2017 05:09 ET (10:09 GMT)
Genus (LSE:GNS)
Historical Stock Chart
From Apr 2024 to May 2024
Genus (LSE:GNS)
Historical Stock Chart
From May 2023 to May 2024